Winter may have surrounded us in darkness, but here at Zelmic, we’re seeing the light – in the form of new opportunities and exciting projects for 2025! After a well-deserved winter break, we’re back, energized, and ready to continue driving innovation and excellence in topical product development, analytical chemistry, in vitro models, and IMP manufacturing…
We are excited to announce that Zelmic will be exhibiting at this year’s NLSdays (Nordic Life Science Days) in Malmö! As one of the leading events in the Nordic region, NLSdays brings together key players in the life science sector, and we’re thrilled to be a part of it again this year. Visit Us at…
Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
September 7th at the Medicon Village in Lund Zelmic will participate at The Future of Swedish & Danish Life Scence held at Medicon Village (Restaurant & Café Inspira). See you there!
September 6th in Copenhagen Zelmic will participate at the event New Updates in Drug Formulation & Bioavailabilityheld at Medicon Valley Alliance headquarters in Copenhagen on September 6th 2023. See you there!
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK